HA, P., D, E., F, C., P, S., TA, H., X, H., . . . J, C. (2023). Genome-wide study of genetic polymorphisms predictive for outcome from first-line oxaliplatin-based chemotherapy in colorectal cancer patients. International journal of cancer, 153(9), 1623. https://doi.org/10.1002/ijc.34663
Chicago Style (17th ed.) CitationHA, Park, et al. "Genome-wide Study of Genetic Polymorphisms Predictive for Outcome from First-line Oxaliplatin-based Chemotherapy in Colorectal Cancer Patients." International Journal of Cancer 153, no. 9 (2023): 1623. https://doi.org/10.1002/ijc.34663.
MLA (9th ed.) CitationHA, Park, et al. "Genome-wide Study of Genetic Polymorphisms Predictive for Outcome from First-line Oxaliplatin-based Chemotherapy in Colorectal Cancer Patients." International Journal of Cancer, vol. 153, no. 9, 2023, p. 1623, https://doi.org/10.1002/ijc.34663.